Our experience with immune checkpoint inhibitors in triple-negative breast cancer patients

被引：0

作者：

Nishio, Minako ^{[1
]}

Kojitani, Yoshiki ^{[1
]}

Kitashiro, Saya ^{[1
]}

Ishiduka, Yasunobu ^{[1
]}

Otsuka, Tomoyuki ^{[1
]}

Nishida, Naohiro ^{[1
]}

Fujisawa, Fumie ^{[1
]}

Sugimoto, Naotoshi ^{[1
]}

Yagi, Toshinari ^{[1
]}

Souma, Ai ^{[2
]}

Kanaoka, Haruka ^{[2
]}

Oyamayama, Yuri ^{[2
]}

Taniguchi, Azusa ^{[2
]}

Nakajima, Satomi ^{[2
]}

Seto, Yukiko ^{[2
]}

Kusama, Hiroki ^{[2
]}

Watanabe, Noriyuki ^{[2
]}

Matsui, Saki ^{[2
]}

Nakayama, Takahiro ^{[2
]}

Kudou, Toshihiro ^{[1
]}

机构：

[1] Osaka Int Canc Inst, Osaka Prefectural Hosp Org, Dept Med Oncol, Osaka, Japan

[2] Osaka Int Canc Inst, Osaka Prefectural Hosp Org, Dept Breast Surg, Osaka, Japan

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.3098

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P67-5

引用

页码：S1465 / S1465

页数：1

共 50 条

[1] Immune Checkpoint Blockade in Patients with Triple-Negative Breast Cancer
Michel, Laura L.
von Au, Alexandra
Mavratzas, Athanasios
Smetanay, Katharina
Schuetz, Florian
Schneeweiss, Andreas
TARGETED ONCOLOGY, 2020, 15 (04) : 415 - 428
[2] Immune Checkpoint Blockade in Patients with Triple-Negative Breast Cancer
Laura L. Michel
Alexandra von Au
Athanasios Mavratzas
Katharina Smetanay
Florian Schütz
Andreas Schneeweiss
Targeted Oncology, 2020, 15 : 415 - 428
[3] Triple-negative breast cancer: Our experience
Bertolini, Alessandro
Menatti, Elisabetta
Fusco, Ornella
Berardi, Eliana
Malugani, Fabio
Fiumano, Mario
ANNALS OF ONCOLOGY, 2007, 18 : 45 - 45
[4] The Evolving Role of Immune Checkpoint Inhibitors in the Treatment of Triple-Negative Breast Cancer
Steiner, Meghan
Tan, Antoinette R.
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (05) : 305 - 315
[5] The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer
Singh, Sima
Numan, Arshid
Maddiboyina, Balaji
Arora, Saahil
Riadi, Yassine
Md, Shadab
Alhakamy, Nabil A.
Kesharwani, Prashant
DRUG DISCOVERY TODAY, 2021, 26 (07) : 1721 - 1727
[6] Breaking Barriers: The Promise and Challenges of Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer
Said, Sawsan Sudqi
Ibrahim, Wisam Nabeel
BIOMEDICINES, 2024, 12 (02)
[7] Opioids and immune checkpoint inhibitors differentially regulate a common immune network in triple-negative breast cancer
Scarpa, Joseph R.
Montagna, Giacomo
Plitas, George
Gulati, Amitabh
Fischer, Gregory W.
Mincer, Joshua S.
FRONTIERS IN ONCOLOGY, 2023, 13
[8] A real-world study of immune checkpoint inhibitors in advanced triple-negative breast cancer
Zhao, Weihong
Zhang, Zheng
Zhang, Yadi
Chen, Yimeng
Zhu, Yimin
Liu, Chuanling
Shao, Jiakang
Zhang, Li
Liu, Mei
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[9] Immune checkpoint inhibitors for triple-negative breast cancer: From immunological mechanisms to clinical evidence
Farshbafnadi, Melina
Khoshbin, Amin Pastaki
Rezaei, Nima
INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 98
[10] A real-world study of immune checkpoint inhibitors in advanced triple-negative breast cancer
Zhang, Zheng
Zhang, Yadi
Liu, Chuanling
Shao, Jiakang
Chen, Yimeng
Zhu, Yimin
Zhang, Li
Qin, Boyu
Kong, Ziqing
Wang, Xixi
Wang, Yutong
Huang, Deqin
Liu, Liqun
Zhou, Yuxin
Tao, Ran
Yang, Zengjie
Liu, Mei
Zhao, Weihong
CANCER INNOVATION, 2023, 2 (03): : 172 - 180

← 1 2 3 4 5 →